CURRENT ACADEMIC ROLE & RESPONSIBILITIES
Dr Vinayak N Anchan’s academic responsibilities include training undergraduate, postgraduate students, and interns.
Besides teaching, he is also involved in,
• Academic & clinical Research
• Performing laser and various cosmetic procedures
• Providing in-patient as well as out-patient care
• Reviewer for the Journal of the European Academy of Dermatology and Venereology and Indian Journal of Dermatology, Venereology and Leprology
SUBJECTS CURRENTLY TEACHING
|Subject||Semester / Year|
|Dermatology, Venereology, Leprosy|
|Degree||Specialisation||Institute||Year of passing|
|MD||Dermatology, Venereology and Leprosy||Institute of Medical Sciences, Banaras Hindu University||2020|
|MBBS||Bangalore Medical College & Research Institute, Bangalore||2016|
|Institution / Organisation||Designation||Role||Tenure|
|Kasturba Medical College, Manipal||Senior Resident||03 Dec 2020 to 31 May 2022|
|Kasturba Medical College , Manipal||Assistant Professor||01 Jun 2022 - till present|
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Evidence Based Medicine and practice of Evidence Based Dermatology • Management of Autoimmune bullous disorder and management of Dermatophytosis, LASER’s, Cosmetology, Dermatoscopy and Dermatopathology
Area of Expertise
Evidence Based Medicine and practice of Evidence Based Dermatology. Management of Autoimmune bullous disorder and management of Dermatophytosis. Lasers, Cosmetology
Area of Research
Professional Affiliations & Contributions
He is a life member of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) and Indian Medical association (IMA)
· Dr. Vinayak N Anchan has completed MD Dermatology, Venereology and Leprosy with 78.75% marks and Distinction from the prestigious Institute of Medical Sciences, Banaras Hindu University.
· He secured gold medal in the qualifying MD Post graduation examination (July 2020).
· He completed his MBBS from the prestigious Bangalore Medical College and Research Institute.
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Br J Dermatol, 183: 840-846. doi:10.1111/bjd.19146
Multidrug therapy with terbinafine and itraconazole is not superior to itraconazole alone in current epidemic of altered dermatophytosis in India: A randomized pragmatic trial.
medRxiv 19003947; doi:10.1101/19003947